Optimizing Oncology Clinical Trials – A Practical Approach
Scimega Research and ACT Oncology are pleased to host this pre-conference workshop entitled Optimizing Oncology Clinical Trials – A Practical Approach. Featuring renowned guest speaker Ken Getz, this interactive ½-day workshop offers you the rare opportunity to share ideas with other industry experts. You will explore several real-world scenarios involving innovative strategies that are helping sponsors overcome the increased complexities and administrative challenges presented by today’s oncology clinical trials.
This is definitely an event you don’t want to miss. Reserve your seat today, as space is limited.
Attendees will receive an Executive Report summarizing the insights and lessons learned from the workshop.
WHEN: TUESDAY, FEBRUARY 14TH 2012 (12:00 – 16:00)
WHERE: SAN FRANCISCO AIRPORT MARRIOTT WATERFRONT (Anaheim Room)
12:00 – 13:00
Registration & lunch
Meet and greet: refreshments and buffet lunch
13:00 – 13:45
State-of-the-industry keynote address by Ken Getz
13:45 – 15:00
Practical approach workshop
3 Stages of an Oncology Clinical Trial.
15:00 – 16:00
Short wrap-up summarizing Lessons Learned
Ken Getz, MBA
Senior Research Fellow, Tufts Center for the Study of Drug Development
Considered an expert on the global investigative site and CRO markets, R&D management strategy and practices, and patient participation in clinical research, Mr. Getz is a well-known speaker at conferences, university symposia, and corporate programs. He has authored two books, ten book chapters, and more than 150 articles in peer-review and trade journals. Mr. Getz is the founder and chairman of CISCRP, and serves on several boards, including the Clinical Trials Transformation Initiative. He is on the editorial boards of the DIA Journal and Contemporary Clinical Trials, and he writes a regular column for Applied Clinical Trials.
Denise Deakin, R.N. B.Sc.
President & Co-Founder, Scimega Research
Ms. Deakin began her career as a registered nurse and gained pertinent experience through her work on clinical trials in the hospital setting, a career in pharma and finally in her active role as President & Chief Evangelist at Scimega, where she is responsible for developing the Scimega brand by fostering a community of like-minded stakeholders in pursuit of continually improving the oncology clinical trial process.
Ms. Deakin is a frequent speaker at industry conferences, seminars and symposiums. She has 20 years of industry experience, and holds a Nursing Diploma and a BSc. from the University of Montreal.
Patricia Devitt Risse, Pharm. D.
President, ACT Oncology
Dr. Devitt Risse brings over two decades of broad-based oncology experience in both global and domestic clinical research environments, including large pharmaceutical companies, biotech companies, and CROs. Armed with these diverse successes, her hard-earned insight, and sophisticated management skills lend stability and long-term commitment to the oncology research community.